Forum Discussion
Perjeta access as second line treatment for HER2+ MBC - suggestions please
I was diagnosed with MBC in Nov 2011 (first diagnosis: mets to liver, bones, lung & brain), and have been feeling very well for years on Herceptin. However, this month, there has been new growth in t...
Thanks Kath @primek
We did a biopsy and the pathology is still HER2+, so no change there meaning it's become resistant to Herceptin. We are trying to find the contact at Roche to write to and explain the situation... fingers crossed we get a compassionate response! The existing company access programs don't appear to apply to my situation.
Appreciate your message, thank you.
We did a biopsy and the pathology is still HER2+, so no change there meaning it's become resistant to Herceptin. We are trying to find the contact at Roche to write to and explain the situation... fingers crossed we get a compassionate response! The existing company access programs don't appear to apply to my situation.
Appreciate your message, thank you.